13441

524824

BALPHARMA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BAL PHARMA LTD. Share Price Today

BAL PHARMA LTD. is currently trading at ₹86.1, up by ₹1.97 from the previous close. The stock touched an intraday high of ₹89.99 and a low of ₹84.35 during the latest trading session. Over the past one year, BAL PHARMA LTD. has delivered a loss of 19.11%, while the stock has gained 6.05% in the last one month.

BAL PHARMA LTD. performance

Today’s low Today’s high
₹ 84.35 ₹ 89.99
₹ 86.19
52 week low 52 week high
₹ 60.00 ₹ 111.18
₹ 86.19
Open Price ₹ 85.78
Prev. Close ₹ 84.12
Volume (Shares) 70095.00
Total traded value ₹ 60.41
Upper Circuit ₹ 100.94
Lower Circuit ₹ 67.30
info

Investment Returns

Over 1 Month 6.05% Over 3 Months 20.56% Over 6 Months 17.18% Over 1 Year -19.11%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BAL PHARMA LTD. fundamentals


  • Market cap (Cr) 137.20
  • P/E Ratio (TTM) 20.45
  • Beta 0.93
  • Book Value / share 65.38
  • Return on equity 8.14%
  • EPS (TTM) 4.24
  • Dividend yield 1.38%
  • Net profit/quarter (Cr) 3.70
info icon alternate text
  • Market cap (Cr) 138.00
  • P/E Ratio (TTM) 20.45
  • Beta 0.74
  • Book Value / share 65.38
  • Return on equity 8.14%
  • EPS (TTM) 4.24
  • Dividend yield 1.38%
  • Net profit/quarter (Cr) 3.70
info icon alternate text

BAL PHARMA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 83.92
Operating Expense 80.38
Net Profit 3.70
Net Profit Margin (%) 4.40
Earnings Per Share (EPS) 2.60
EBITDA 10.39
Effective Tax Rate (%) -11.78
Particulars DEC 2025 (Values in Cr)
Revenue 87.49
Operating Expense 85.89
Net Profit 1.95
Net Profit Margin (%) 2.22
Earnings Per Share (EPS) 1.22
EBITDA 10.03
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 73.75
Operating Expense 74.11
Net Profit 0.78
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.49
EBITDA 6.91
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 65.64
Operating Expense 66.05
Net Profit 0.32
Net Profit Margin (%) 0.48
Earnings Per Share (EPS) 0.20
EBITDA 6.89
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 81.78
Operating Expense 79.96
Net Profit 5.61
Net Profit Margin (%) 6.85
Earnings Per Share (EPS) 3.51
EBITDA 8.82
Effective Tax Rate (%) -99.28
Particulars MAR 2026 (Values in Cr)
Revenue 310.80
Operating Expense 306.43
Net Profit 6.75
Net Profit Margin (%) 2.17
Earnings Per Share (EPS) 4.51
EBITDA 34.24
Effective Tax Rate (%) -6.12
Particulars MAR 2025 (Values in Cr)
Revenue 302.50
Operating Expense 298.92
Net Profit 7.80
Net Profit Margin (%) 2.57
Earnings Per Share (EPS) 4.89
EBITDA 32.23
Effective Tax Rate (%) -36.12
Particulars MAR 2024 (Values in Cr)
Revenue 338.54
Operating Expense 331.52
Net Profit 7.73
Net Profit Margin (%) 2.28
Earnings Per Share (EPS) 6.72
EBITDA 33.83
Effective Tax Rate (%) 17.06
Particulars MAR 2023 (Values in Cr)
Revenue 303.10
Operating Expense 296.73
Net Profit 6.13
Net Profit Margin (%) 2.02
Earnings Per Share (EPS) 3.90
EBITDA 28.49
Effective Tax Rate (%) 28.30
Particulars MAR 2022 (Values in Cr)
Revenue 280.37
Operating Expense 274.79
Net Profit 8.58
Net Profit Margin (%) 3.06
Earnings Per Share (EPS) 5.79
EBITDA 29.70
Effective Tax Rate (%) 28.85
Particulars MAR 2025 (Values in Cr)
Book Value / Share 48.63
ROE % 9.69
ROCE % 9.78
Total Debt to Total Equity 1.94
EBITDA Margin 10.55
Particulars MAR 2024 (Values in Cr)
Book Value / Share 45.56
ROE % 10.97
ROCE % 11.29
Total Debt to Total Equity 1.99
EBITDA Margin 9.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 40.66
ROE % 4.28
ROCE % 9.16
Total Debt to Total Equity 1.92
EBITDA Margin 8.61
Particulars MAR 2022 (Values in Cr)
Book Value / Share 38.92
ROE % 9.04
ROCE % 11.02
Total Debt to Total Equity 1.90
EBITDA Margin 9.92
Particulars MAR 2021 (Values in Cr)
Book Value / Share 35.52
ROE % 8.89
ROCE % 9.32
Total Debt to Total Equity 2.16
EBITDA Margin 10.29
Particulars MAR 2025 (Values in Cr)
Book Value / Share 62.07
ROE % 8.14
ROCE % 9.42
Total Debt to Total Equity 1.45
EBITDA Margin 10.72
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.74
ROE % 8.19
ROCE % 10.41
Total Debt to Total Equity 1.37
EBITDA Margin 10.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 61.21
ROE % 6.69
ROCE % 10.08
Total Debt to Total Equity 1.22
EBITDA Margin 9.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 58.28
ROE % 9.36
ROCE % 11.20
Total Debt to Total Equity 1.21
EBITDA Margin 10.22
Particulars MAR 2021 (Values in Cr)
Book Value / Share 52.88
ROE % 12.53
ROCE % 12.18
Total Debt to Total Equity 1.40
EBITDA Margin 11.75
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 8.05
Total Assets 335.69
Total Liabilities 335.69
Total Equity 77.40
Share Outstanding 1
Price to Book Ratio 1.34
Return on Assets (%) 2.14
Return on Capital (%) 3.17
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.29
Total Assets 319.83
Total Liabilities 319.83
Total Equity 71.97
Share Outstanding 1
Price to Book Ratio 1.55
Return on Assets (%) 2.31
Return on Capital (%) 3.49
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.61
Total Assets 313.17
Total Liabilities 313.17
Total Equity 63.70
Share Outstanding 1
Price to Book Ratio 1.09
Return on Assets (%) 0.82
Return on Capital (%) 1.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.39
Total Assets 260.53
Total Liabilities 260.53
Total Equity 58.49
Share Outstanding 1
Price to Book Ratio 1.85
Return on Assets (%) 2.15
Return on Capital (%) 3.59
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.85
Total Assets 240.08
Total Liabilities 240.08
Total Equity 53.35
Share Outstanding 1
Price to Book Ratio 1.02
Return on Assets (%) 1.97
Return on Capital (%) 3
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 7.93
Total Assets 350.56
Total Liabilities 350.56
Total Equity 98.82
Share Outstanding 1
Price to Book Ratio 1.34
Return on Assets (%) 2.22
Return on Capital (%) 3.2
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.15
Total Assets 334.22
Total Liabilities 334.22
Total Equity 92.83
Share Outstanding 1
Price to Book Ratio 1.55
Return on Assets (%) 2.31
Return on Capital (%) 3.41
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.35
Total Assets 347.70
Total Liabilities 347.70
Total Equity 96.03
Share Outstanding 1
Price to Book Ratio 1.09
Return on Assets (%) 1.76
Return on Capital (%) 2.77
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.09
Total Assets 289.76
Total Liabilities 289.76
Total Equity 87.32
Share Outstanding 1
Price to Book Ratio 1.85
Return on Assets (%) 2.96
Return on Capital (%) 4.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.71
Total Assets 261.53
Total Liabilities 261.53
Total Equity 79.31
Share Outstanding 1
Price to Book Ratio 1.02
Return on Assets (%) 3.47
Return on Capital (%) 4.96
Particulars MAR 2025 (Values in Cr)
Net Income 5.13
Cash from Operations 22.39
Cash from Investing -14.91
Cash from Financing -7.84
Net change in Cash -2.44
Free Cash Flow 41.17
Particulars MAR 2024 (Values in Cr)
Net Income 9.04
Cash from Operations 27.34
Cash from Investing -18.89
Cash from Financing -1.20
Net change in Cash 2.70
Free Cash Flow 38.32
Particulars MAR 2023 (Values in Cr)
Net Income 4.74
Cash from Operations -1.03
Cash from Investing -22.18
Cash from Financing 24.09
Net change in Cash 0.37
Free Cash Flow 13.61
Particulars MAR 2022 (Values in Cr)
Net Income 9.18
Cash from Operations 27.99
Cash from Investing -9.48
Cash from Financing -17.22
Net change in Cash 0.08
Free Cash Flow 36.46
Particulars MAR 2021 (Values in Cr)
Net Income 4.10
Cash from Operations 22.44
Cash from Investing -5.53
Cash from Financing -16.63
Net change in Cash 0.16
Free Cash Flow 22.44
Particulars MAR 2025 (Values in Cr)
Net Income 5.73
Cash from Operations 22.39
Cash from Investing -14.90
Cash from Financing -7.83
Net change in Cash -2.41
Free Cash Flow 41.16
Particulars MAR 2024 (Values in Cr)
Net Income 9.31
Cash from Operations 33.08
Cash from Investing -18.84
Cash from Financing -6.93
Net change in Cash 2.76
Free Cash Flow 43.99
Particulars MAR 2023 (Values in Cr)
Net Income 8.54
Cash from Operations 5.87
Cash from Investing -22.08
Cash from Financing 17.12
Net change in Cash 0.41
Free Cash Flow 20.41
Particulars MAR 2022 (Values in Cr)
Net Income 12.05
Cash from Operations 31.68
Cash from Investing -13.43
Cash from Financing -17.21
Net change in Cash -0.07
Free Cash Flow 39.25
Particulars MAR 2021 (Values in Cr)
Net Income 9.79
Cash from Operations 10.34
Cash from Investing -6.65
Cash from Financing -3.36
Net change in Cash 0.21
Free Cash Flow 13.15
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 13.39 1.56 248.29 23.12 38.85
BLISS GVS PHARMA LTD 438.10 35.56 3.89 4646.32 118.35 462.70
CIPLA LTD 1388.80 29.47 3.25 112193.56 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.80 14.94 2.45 997.12 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 22.66 4.17 248.29 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 557.75 25.00 4.35 1612.49 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8243.90 107.66 23.61 20609.75 7630.00 10653.05
BLISS GVS PHARMA LTD 438.10 47.26 4.02 4646.32 118.35 462.70

BAL PHARMA LTD. shareholding pattern

Holding
49.0%
50.85%
0.13%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

BAL PHARMA LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
86.19 2.46 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 86.00
  • 26 Days 84.30
  • 10 Days 86.20
  • 50 Days 81.20
  • 12 Days 86.10
  • 100 Days 78.80
  • 20 Days 85.20
  • 200 Days 81.30
85.56 PIVOT
First Support 82.13 First Resistance 87.55 Second Support 80.14 Second Resistance 90.98 Third Support 76.71 Third Resistance 92.97
RSI 53.50 ADX 38.29 MACD 1.85 Williams % R -75.58 Commodity Channel Index (CCI) 14.22
Date 2026-06-12 Week 10262.00 Same Day 15256.00 Month 23979.00
1 Year 0.93 3 Year 0.86
Over 1 Month
6.05% down
Over 1 Year
-19.11% down
Over 3 Months
20.56% down
Over 3 Years
-0.46% down
Over 6 Months
17.18% down
Over 5 Years
-2.63% down

BAL PHARMA LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2025 1.2 Final 18 Sep 2025 Equity shares
17 Sep 2024 1.2 Final 19 Sep 2024 Equity shares
18 Sep 2023 1.0 Final 19 Sep 2023 Equity shares
13 Sep 2022 1.0 Final 15 Sep 2022 Equity shares
16 Sep 2021 1.0 Final 18 Sep 2021 Equity shares
17 Sep 2019 1.0 Final 19 Sep 2019 Equity shares
14 Sep 2018 1.0 Final 18 Sep 2018 Equity shares
14 Sep 2017 1.0 Final 18 Sep 2017 Equity shares
15 Sep 2016 1.0 Final 18 Sep 2016 Equity shares
15 Sep 2015 1.0 Final 18 Sep 2015 Equity shares
12 Sep 2014 1.0 Final 16 Sep 2014 Equity shares
12 Sep 2013 0.75 Final 16 Sep 2013 Equity shares
17 Sep 2009 0.75 Final 22 Sep 2009 Equity shares
09 Sep 2008 1.0 Final 11 Sep 2008 Equity shares
07 Sep 2007 0.75 Final 11 Sep 2007 Equity shares
09 Sep 2005 0.0 Final 13 Sep 2005 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2025 1.2 Final 18 Sep 2025 Equity shares
17 Sep 2024 1.2 Final 19 Sep 2024 Equity shares
18 Sep 2023 1.0 Final 19 Sep 2023 Equity shares
13 Sep 2022 1.0 Final 15 Sep 2022 Equity shares
16 Sep 2021 1.0 Final 18 Sep 2021 Equity shares
17 Sep 2019 1.0 Final 19 Sep 2019 Equity shares
14 Sep 2018 1.0 Final 18 Sep 2018 Equity shares
14 Sep 2017 1.0 Final 18 Sep 2017 Equity shares
15 Sep 2016 1.0 Final 18 Sep 2016 Equity shares
15 Sep 2015 1.0 Final 18 Sep 2015 Equity shares
12 Sep 2014 1.0 Final 16 Sep 2014 Equity shares
12 Sep 2013 0.75 Final 16 Sep 2013 Equity shares
17 Sep 2009 0.75 Final 22 Sep 2009 Equity shares
09 Sep 2008 1.0 Final 11 Sep 2008 Equity shares
07 Sep 2007 0.75 Final 11 Sep 2007 Equity shares
09 Sep 2005 0.0 Final 13 Sep 2005 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Bal Pharma Ltd?

Answer Field

Bal Pharma Ltd share price is for NSE ₹ 86.10 & for BSE ₹ 86.70 as on Jun 12 2026 03:29 PM.

What is the Market Cap of Bal Pharma Ltd Share?

Answer Field

The market cap of Bal Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 12 2026 03:29 PM.

What is the 52 Week High and Low of Bal Pharma Ltd?

Answer Field

The 52 Week High and Low of Bal Pharma Ltd for NSE is ₹ 111.18 and ₹ 60.00 and for BSE is ₹ 112.97 and ₹ 59.69.

What is 1 year return for Bal Pharma Ltd?

Answer Field

The 1 year returns on the stock has been -19.11%.

What is the P/E Ratio of Bal Pharma Ltd Share?

Answer Field

As on Jun 12 2026 03:29 PM the price-to-earnings (PE) ratio for Bal Pharma Ltd share is 20.45.

What is the PB ratio of Bal Pharma Ltd Share?

Answer Field

As on Jun 12 2026 03:29 PM, the price-to-book (PB) ratio for Bal Pharma Ltd share is 65.38.

How to Buy Bal Pharma Ltd Share?

Answer Field

You can trade in Bal Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bal Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Bal Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bal Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|